Leucadia National - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Leucadia National ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,346,022
+130.0%
109,062
+200.4%
0.03%
+138.5%
Q2 2023$1,454,982
-48.0%
36,311
-47.1%
0.01%
-40.9%
Q1 2023$2,800,627
+6.4%
68,626
+0.7%
0.02%
+22.2%
Q4 2022$2,632,23768,1750.02%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders